BUSINESS

• Takeda Returns Japan Rights for Some Amgen Products
  June 27, 2016

• Teijin Pharma Will Block Feburic Generic Erosions by Expanding Indications: President
  June 24, 2016

• Cellular Dynamics, US National Eye Institute Ink Pact to Advance Cell Transplantation Therapy for AMD
  June 24, 2016

• Univ. of Tokyo, Astellas to Codevelop Rice-Based Oral Cholera Vaccine
  June 24, 2016

• Sanofi’s Antibody Drug for Atopic Dermatitis Close to Regulatory Filing
  June 23, 2016

• Asahi Kasei Inks Collaboration with Finland’s Orion on Pain Therapies
  June 23, 2016

• Interview: Bayer Yakuhin Chief Spearheading Initiatives to Trigger Behavior Change in Employees
  June 23, 2016

• Fujifilm Inks 1st License Deal for Avigan Patents with Chinese Pharma
  June 23, 2016

• Takeda to Partner with US NPO for Joint Program to Explore Lead Compounds for TB Therapies
  June 23, 2016

• Bayer Japan Revs Up Drive to Spark Behavior Change, Offers Patient Insights to Back Office Staffers
  June 22, 2016

• Takao Hayakawa Tapped as New Chief of Kaketsuken
  June 22, 2016

• Takeda Kicks Off PIIb Trial for Norovirus Vaccine in US
  June 22, 2016

• AnGes MG Alters Global Collategene Strategy, Initial Focus Now on US
  June 21, 2016

• Mitsubishi Tanabe Files US NDA for ALS Drug Edaravone, Eyes Nod by March-End
  June 21, 2016

• Jannie Oosthuizen to Lead MSD Japan from July
  June 21, 2016

• Cyramza Earns Lung Cancer Indication in Japan
  June 21, 2016

• Co-Dio AG Makes Debut; Kipres, Ecard AGs to Hit Market Early September
  June 20, 2016

• AMED-Backed Neuropathic Pain Drug Now in PI: Nippon Chemiphar, Kyushu University
  June 20, 2016

• Takeda Gains Access to US Cancer Genomic Network
  June 20, 2016

• Takeda’s Partnership with Tri-I TDI Now Encompasses Antibody Drug Discovery
  June 20, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 477
• 478
• 479
• 480
• 481
• 482
• 483
• 484
• 485
• …
• Next ›
• 最終 »